{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T22:43:10Z","timestamp":1772145790235,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.tmrv.2007.03.003","type":"journal-article","created":{"date-parts":[[2007,6,14]],"date-time":"2007-06-14T05:04:48Z","timestamp":1181797488000},"page":"223-236","source":"Crossref","is-referenced-by-count":45,"title":["The Evidence for the Use of Recombinant Human Activated Factor VII in the Treatment of Bleeding Patients With Quantitative and Qualitative Platelet Disorders"],"prefix":"10.1016","volume":"21","author":[{"given":"Man-Chiu","family":"Poon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2007.03.003_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1046\/j.1537-2995.1997.37697335157.x","article-title":"Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets","volume":"37","author":"Gelb","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2007.03.003_bib2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1537-2995.2002.00174.x","article-title":"Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population","volume":"42","author":"Dodd","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2007.03.003_bib3","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1046\/j.1537-2995.2001.41111331.x","article-title":"Don't bug me: the problem of bacterial contamination of blood components\u2014Challenges and solutions","volume":"41","author":"Jacobs","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2007.03.003_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000031151","article-title":"Bacterial contamination of blood components","volume":"78","author":"Engelfriet","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2007.03.003_bib5","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V94.11.3951","article-title":"Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia","volume":"94","author":"Poon","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib6","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1538-7836.2004.00767.x","article-title":"Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey","volume":"2","author":"Poon","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-16890","article-title":"Recombinant activated factor VII (rFVIIa): Characterization, manufacturing, and clinical development","volume":"27","author":"Jurlander","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/clpt.1994.80","article-title":"Pharmacokinetics and pharmacodynamics of recombinant factor VIIa","volume":"55","author":"Lindley","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tmrv.2007.03.003_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2516.2004.00925.x","article-title":"Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A","volume":"10","author":"Villar","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2007.03.003_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF02994016","article-title":"Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitors","volume":"73","author":"Shirahata","year":"2001","journal-title":"Int J Hematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib11","first-page":"640","article-title":"Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency","volume":"86","author":"Berrettini","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2007.03.003_bib12","series-title":"Basic principles and clinical practice","first-page":"91","article-title":"Tissue factor structure and function. Hemostasis and thrombosis","author":"Morrissey","year":"2006"},{"key":"10.1016\/j.tmrv.2007.03.003_bib13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(88)90259-0","article-title":"Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy","volume":"2","author":"Hedner","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2007.03.003_bib14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1055\/s-0038-1665434","article-title":"The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: A multicentre study","volume":"78","author":"Hay","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1365-2516.1998.00209.x","article-title":"A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group","volume":"4","author":"Lusher","year":"1998","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2007.03.003_bib16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0037-1615357","article-title":"Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery","volume":"80","author":"Shapiro","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0049-3848(00)00220-6","article-title":"The continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complications","volume":"99","author":"Baudo","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.tmrv.2007.03.003_bib18","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.V95.4.1330.004k28_1330_1335","article-title":"Inhibition of thrombin generation by the zymogen factor VII: Implications for the treatment of hemophilia A by factor VIIa","volume":"95","author":"van't Veer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.V99.3.923","article-title":"Mechanism of factor VIIa\u2013dependent coagulation in hemophilia blood","volume":"99","author":"Butenas","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib21","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1046\/j.1538-7836.2003.00181.x","article-title":"How factor VIIa works in hemophilia","volume":"1","author":"Butenas","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/FIX","volume":"1","author":"He","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V99.1.175","article-title":"Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A","volume":"99","author":"Lisman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2141.2001.02870.x","article-title":"High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system","volume":"114","author":"Kjalke","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1537-2995.2003.00427.x","article-title":"Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders","volume":"43","author":"Gal\u00e1n","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2007.03.003_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1538-7836.2005.01227.x","article-title":"Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count","volume":"3","author":"Lisman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI118859","article-title":"Inhibition of platelet-mediated, tissue factor\u2013induced thrombin generation by the mouse\/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and \u201cclinical restenosis\u201d","volume":"98","author":"Reverter","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2007.03.003_bib28","series-title":"Platelets","first-page":"1251","article-title":"Factor VIIa","author":"Poon","year":"2006"},{"key":"10.1016\/j.tmrv.2007.03.003_bib29","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2002-09-2761","article-title":"Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor\u2013independent thrombin generation","volume":"101","author":"Lisman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0049-3848(81)90207-3","article-title":"Platelet interaction with polymerizing fibrin in Glanzmann's thrombasthenia","volume":"23","author":"Niewiarowski","year":"1981","journal-title":"Thromb Res"},{"key":"10.1016\/j.tmrv.2007.03.003_bib31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1055\/s-0038-1651036","article-title":"Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa","volume":"62","author":"McGregor","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib32","first-page":"518a","article-title":"Polymeric fibrin interacts with platelets independently from integrin aIIob3","volume":"98","author":"Osdoit","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib33","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2003-07-2287","article-title":"Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor\u2013independent fibrin generation","volume":"103","author":"Lisman","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib34","doi-asserted-by":"crossref","first-page":"21173","DOI":"10.1074\/jbc.M008249200","article-title":"Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib","volume":"276","author":"Soslau","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2007.03.003_bib35","first-page":"1043","article-title":"Haemostatic effect of factor VIIa in thrombocytopenic rabbits","volume":"86","author":"Hedner","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0049-3848(03)00146-4","article-title":"Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits","volume":"109","author":"Tranholm","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.tmrv.2007.03.003_bib37","first-page":"159","article-title":"Clinical experience with recombinant factor VIIa in patients with thrombocytopenia","volume":"26","author":"Kristensen","year":"1996","journal-title":"Haemostasis"},{"key":"10.1016\/j.tmrv.2007.03.003_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/107602960501100406","article-title":"Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: An audit of the clinical use of recombinant activated factor VII","volume":"11","author":"Brenner","year":"2005","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.10056","article-title":"Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage","volume":"69","author":"Gerotziafas","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1365-2141.2002.381113.x","article-title":"The use of recombinant factor VIIa in a Jehovah's witness with auto-immune thrombocytopenia and post-splenectomy haemorhage","volume":"119","author":"Waddington","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib41","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2141.2003.04151_2.x","article-title":"Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura","volume":"120","author":"Culic","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.thj.6200395","article-title":"Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia","volume":"5","author":"Virchis","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.tmrv.2007.03.003_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-0037-1616257","article-title":"Use of recombinant factor VIIa in a thrombocytopenic patient with spontaneous intracerebral haemorrhage","volume":"93","author":"Busani","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.0958-7578.2005.00564.x","article-title":"Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment","volume":"15","author":"Barnes","year":"2005","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2007.03.003_bib45","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1055\/s-0037-1613879","article-title":"Recombinant factor VIIa for bleeding in refractory thrombocytopenia","volume":"83","author":"Vidarsson","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib46","first-page":"83","article-title":"Treatment of refractory thrombocytopenic bleeding with rFVIIa: a case report","volume":"100","author":"Billio","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib47","first-page":"78","article-title":"Successful treatment of life threatening haemorrhage with rVIIa during autologous peripheral blood stem cell transplantation complicated by platelet refractoriness","volume":"100","author":"Watson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib48","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1538-7836.2003.t01-5-00177.x","article-title":"Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia","volume":"1","author":"Hoffman","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib49","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bmt.1704058","article-title":"Use of recombinant factor VIIa in life-threatening bleeding following autologous peripheral blood stem cell transplantation complicated by platelet refractoriness","volume":"31","author":"Culligan","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.03.003_bib50","first-page":"243","article-title":"Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies","volume":"89","author":"De Fabritiis","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2007.03.003_bib51","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00001721-200404000-00011","article-title":"Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven)","volume":"15","author":"Zulfikar","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tmrv.2007.03.003_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2257.2004.00604.x","article-title":"Immediate haemostasis with recombinant factor VIIa for haemorrhage following Hickman line insertion in acute myeloid leukaemia","volume":"26","author":"Osborne","year":"2004","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.mbc.0000161569.66764.70","article-title":"Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia","volume":"16","author":"Kurekci","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tmrv.2007.03.003_bib54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ajh.20506","article-title":"Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization","volume":"81","author":"Savani","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib55","first-page":"155","article-title":"Recombinant factor VIIa (rFVIIa) is effective at massive bleeding after caesarean section\u2014A case report","volume":"26","author":"Sokolic","year":"2002","journal-title":"Coll Antropol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib56","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000064699","article-title":"Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome","volume":"108","author":"Zupancic-Salek","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.TA.0000135142.80368.65","article-title":"A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome","volume":"57","author":"Dart","year":"2004","journal-title":"J Trauma"},{"key":"10.1016\/j.tmrv.2007.03.003_bib58","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/01.AOG.0000127943.68645.96","article-title":"Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy","volume":"103","author":"Merchant","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib59","doi-asserted-by":"crossref","first-page":"A14","DOI":"10.1097\/00001721-200110000-00041","article-title":"Use of recombinant factor VIIa in platelet disorders\u2014A single centre experience","volume":"12","author":"Thomas","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tmrv.2007.03.003_bib60","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.mbc.0000169222.46420.cf","article-title":"Management of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets","volume":"16","author":"Heuer","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tmrv.2007.03.003_bib61","first-page":"62b","article-title":"Use of recombinant activated factor VII (rFVIIa) in two children with idiopathic thrombocytopenic purpura (ITP)","volume":"98","author":"Minniti","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1532\/IJH97.E0415","article-title":"Recombinant factor VIIa is an effective therapy for abdominal surgery and severe thrombocytopenia: A case report","volume":"81","author":"Conesa","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib63","first-page":"77b","article-title":"Successful use of recombinant factor VIIa to prevent bleeding during major surgery in a patient with severe immune thrombocytopenia","volume":"100","author":"Klamroth","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2007.03.003_bib64","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/j.1538-7836.2005.01523.x","article-title":"Recombinant activated factor VII in treatment of bleeding complication following hematopoietic stem cell transplantation","volume":"3","author":"Pihusch","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1703157","article-title":"Off-label use of recombinant factor VIIa in patients following bone marrow transplantation","volume":"28","author":"Blatt","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2007.03.003_bib66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.20113","article-title":"Near-fatal uterine hemorrhage during induction chemotherapy for acute myeloid leukemia: A case report of bilateral uterine artery embolization","volume":"77","author":"Phelan","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-9560-4-1","article-title":"Ineffective off-label use of recombinant activated factor VII in a case of bone-marrow transplantation\u2013related gastrointestinal bleeding","volume":"4","author":"Eller","year":"2006","journal-title":"J. Thromb"},{"key":"10.1016\/j.tmrv.2007.03.003_bib68","first-page":"981","article-title":"A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa","volume":"75","author":"Tengborn","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib69","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1055\/s-0037-1614920","article-title":"Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa","volume":"82","author":"Chuansumrit","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib70","first-page":"349","article-title":"Thrombotic complications in two patients receiving NovoSeven","volume":"6","author":"Robinson","year":"2000","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2007.03.003_bib71","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0037-1613884","article-title":"Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures","volume":"83","author":"d'Oiron","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib72","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/bja\/88.5.734","article-title":"Peripartum management of a patient with Glanzmann's thrombasthenia using Thrombelastograph","volume":"88","author":"Monte","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.tmrv.2007.03.003_bib73","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1023\/A:1019605803467","article-title":"Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia","volume":"47","author":"vanBuuren","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.tmrv.2007.03.003_bib74","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2141.2003.04286.x","article-title":"The use of recombinant factor VIIa in children with inherited platelet function disorders","volume":"121","author":"Almeida","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib75","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00001721-200302000-00011","article-title":"Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia","volume":"14","author":"Chuansumrit","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tmrv.2007.03.003_bib76","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/08880010390220135","article-title":"Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia","volume":"20","author":"Caglar","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/107602960300900213","article-title":"Glanzmann's thrombasthenia proposed optimal management during surgery and delivery","volume":"9","author":"Bell","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.2004.04878.x","article-title":"Use of recombinant factor VIIa in inherited platelet disorders","volume":"125","author":"Kaleelrahman","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib79","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1515\/JPM.2004.147","article-title":"The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery","volume":"32","author":"Kale","year":"2004","journal-title":"J Perinat Med"},{"key":"10.1016\/j.tmrv.2007.03.003_bib80","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1213\/01.ANE.0000131726.09685.BF","article-title":"A patient with Glanzmann's thrombasthenia for emergent abdominal surgery","volume":"99","author":"Uzunlar","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.tmrv.2007.03.003_bib81","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1055\/s-0037-1614304","article-title":"Recombinant factor VIIa in a patient with Glanzmann's thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment","volume":"92","author":"Coppola","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib82","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00246-004-0919-7","article-title":"Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia","volume":"26","author":"Yilmaz","year":"2005","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib83","first-page":"17","article-title":"A case of Glanzmann's thrombasthenia successfully treated with recombinant factor VIIa during a surgical procedure: Observations on the monitoring and the mechanism of action of this drug","volume":"91","author":"Dargaud","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2007.03.003_bib84","first-page":"621","article-title":"Recombinant activated factor VII as haemostatic agent in Glanzmann's thrombasthenia","volume":"82","author":"Musso","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib85","first-page":"64","article-title":"Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb\/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions","volume":"45","author":"Devecioglu","year":"2003","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.tmrv.2007.03.003_bib86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1423-0410.1991.tb00925.x","article-title":"Antibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann's thrombasthenia and multiple anti-platelet antibodies","volume":"61","author":"Ito","year":"1991","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2007.03.003_bib87","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2141.2002.03936.x","article-title":"Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti\u2013glycoprotein IIb-IIIa antibodies","volume":"119","author":"Martin","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib88","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1053\/j.seminhematol.2005.11.009","article-title":"Glanzmann's thrombasthenia treatment: A prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents","volume":"43","author":"Poon","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib89","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0037-1615209","article-title":"Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa","volume":"80","author":"Peters","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib90","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00277-005-1080-y","article-title":"Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome","volume":"84","author":"Ozelo","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.tmrv.2007.03.003_bib91","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00001721-200209000-00010","article-title":"Successful thyroidectomy in a patient with Hermansky-Pudlak syndrome treated with recombinant activated factor VII and platelet concentrates","volume":"13","author":"PozoPozo","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tmrv.2007.03.003_bib92","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/pbc.20199","article-title":"Modification of biological parameters after treatment with recombinant factor VIIa in a patient with thrombocytopathy due to storage pool disease","volume":"44","author":"Langendonck","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tmrv.2007.03.003_bib93","first-page":"299","article-title":"Use of recombinant factor VIIa (NovoSeven) for dental extraction in a patient affected by platelet-type (pseudo-) von Willebrand disease","volume":"4","author":"Fressinaud","year":"1998","journal-title":"Haemophilia"},{"key":"10.1016\/j.tmrv.2007.03.003_bib94","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.mbc.0000224853.50248.6f","article-title":"Use of recombinant activated factor VII to control bleeding in a young child with qualitative platelet disorder: A case report","volume":"17","author":"Inagaki","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tmrv.2007.03.003_bib95","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0037-1615168","article-title":"Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII [letter]","volume":"80","author":"Meijer","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-0037-1615210","article-title":"Recombinant factor VIIa in severe uremic bleeding","volume":"80","author":"R\u00e9v\u00e9sz","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib97","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0037-1616256","article-title":"The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding","volume":"93","author":"Cervera","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib98","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1538-7836.2004.00944.x","article-title":"Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity","volume":"2","author":"Aledort","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib99","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1538-7836.2004.00759.x","article-title":"Recombinant factor VIIa: Review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors","volume":"2","author":"Abshire","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib100","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1538-7836.2005.01254.x","article-title":"Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity\u2014A rebuttal","volume":"3","author":"Sallah","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2007.03.003_bib101","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1046\/j.0041-1132.2003.00577.x","article-title":"Recombinant FVIIa in the management of uncontrolled hemorrhage","volume":"43","author":"O'connell","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2007.03.003_bib102","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796307000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796307000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T02:45:26Z","timestamp":1587609926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796307000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0887796307000193"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2007.03.003","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}